GoldenGolden
Dnalite Therapeutics, Inc.

Dnalite Therapeutics, Inc.

DNALite Therapeutics, Inc. is a biotechnology company focused on developing prevention and treatment for gastrointestinal diseases.

Dnalite Therapeutics, Inc is an American company that focuses on creating oral medicines for the gastrointestinal tracts. The company's innovation is the creation of alternatives to surgeries for gastrointestinal diseases. It was founded by Mubhij Ahmad and Timothy Day in 2016, with its headquarters in San Francisco.

Timeline

August 2018
Dnalite Therapeutics, Inc. raises a $1,500,000 seed round from Baldota family, Berkeley Catalyst Fund, Blue Bear Ventures, BrightGene, SOSV, SVE Capital and University of California, Berkeley.
July 19, 2017
Dnalite Therapeutics, Inc. was founded by Mubhij Ahmad and Timothy Day.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
DNAlite Therapeutics Inc funding round, August 2018
1,500,000
August 2018
3 Results
Results per page:
Page 1 of 1

SBA Awards

SBA Award
Agency
Award Type
Amount (USD)
Date Awarded
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Mubhij Ahmad

Employee

Timothy Day

Founder

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.